5HT2C receptor agonists and antagonists in animal models of anxiety

By Martin J.R.   Bouml s M.   Jenck F.   Kouml hler C.   Moreau J.-L.   Sleight A.J.   Stadler H.   Wichmann J.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 209-209

Elsevier

Access to resources Recommend Favorite

5-HT2C Receptor Agonists as Potential Drugs for the Treatment of Obesity

By  

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 8, 2003-05 ,pp. : 885-897

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic potential of NMDA receptor antagonists in the treatment of alcohol and substance use disorders

By Bisaga A.   Popik P.   Bespalov A.Y.   Danysz W.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 10, 2000-10 ,pp. : 2233-2248

Informa Healthcare

Access to resources Recommend Favorite

Synthesis, pharmacology and therapeutic potential of 10-methoxypyrazino[1,2-a]indoles, partial agonists at the 5HT 2C receptor

By Bos M.   Jenck F.   Martin J.   Moreau J.   Mutel V.   Sleight A.   Widmer U.  

European Journal of Medicinal Chemistry, Vol. 32, Iss. 3, 1997-01 ,pp. : 253-261

Elsevier

Access to resources Recommend Favorite

The 5-HT2C receptor as a target for mood disorders

By Serretti Alessandro   Artioli Paola   De Ronchi Diana  

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 1, 2004-02 ,pp. : 15-23

Informa Healthcare

Access to resources Recommend Favorite